BioCentury
ARTICLE | Company News

Isis, Nitto Denko sales and marketing update

November 15, 2004 8:00 AM UTC

The companies jointly developed a solid support matrix for the manufacture of oligonucleotides, including antisense and aptamers. The product will be marketed by Nitto subsidiary Kinovate Life Science...